Publikationen

 

Marcin Zaradzki

 

---

2019

Arif R, Franz M, Remes A, Zaradzki M, Hecker M, Karck M, Müller OJ, Kallenbach K, Wagner AH (2019)

Reduction of Transplant Vasculopathy by Intraoperative Nucleic Acid-based Therapy in a Mouse Aortic Allograft Model.

Thorac Cardiovasc Surg. 2019 Sep;67(6):503-512. doi: 10.1055/s-0038-1673633. Epub 2018 Oct 23.

 

Kremer J, Farag M, Zaradzki M, Szabó G, Ruhparwar A, Kallenbach K, Karck M, Arif R (2019)

The reimplantation valve-sparing aortic root replacement technique for patients with Marfan syndrome: A single-center experience.

Sci Rep. 2019 Aug 19;9(1):12021. doi: 10.1038/s41598-019-48572-9.

 

---

2018

Wagner AH, Zaradzki M, Arif R, Remes A, Müller OJ, Kallenbach K (2018)

Marfan syndrome: A therapeutic challenge for long-term care.

Biochem Pharmacol. 2019 Jun;164:53-63. doi: 10.1016/j.bcp.2019.03.034. Epub 2019 Mar 27. Review.

 

Bhushan R, Altinbas L, Jäger M, Zaradzki M, Lehmann D, Timmermann B, Clayton NP, Zhu Y, Kallenbach K, Kararigas G, Robinson PN (2019)

An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology.

J Cell Mol Med. 2019 Apr;23(4):2526-2535. doi: 10.1111/jcmm.14137. Epub 2019 Jan 24.

 

Morath B, Green K, Zaradzki M, Heid J, Karck M, Hoppe-Tichy T (2018)

Subtherapeutic valproic acid plasma concentrations under concomitant dipyrone therapy in an epilepsy patient-a case report.

Eur J Clin Pharmacol. 2018 May;74(5):675-677. doi: 10.1007/s00228-018-2417-5. Epub 2018 Jan 23

 

---

2017

Arif R, Zaradzki M, Remes A, Seppelt P, Kunze R, Schröder H, Schwill S, Ensminger SM, Robinson PN, Karck M, Müller OJ, Hecker M, Wagner AH, Kallenbach K (2017)

AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome.

Mol Ther Nucleic Acids. 2017 Dec 15;9:69-79. doi: 10.1016/j.omtn.2017.08.014. Epub 2017 Sep 20.